Skip to content
Screener

Kura Oncology KURA Asset turnover

Asset turnover at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.5×0.0×
Amgen logo
AmgenAMGN
0.4×0.0×
Exelixis logo
ExelixisEXEL
0.9×+0.1×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
0.4×+0.3×
AbbVie logo
AbbVieABBV
0.5×+0.1×
Nuvation Bio logo
Nuvation BioNUVB
0.2×+0.2×

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M—
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$849.57M+76.7%
Enterprise value$834.76M+99.5%
P/S11.9×+3.3×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Calculated from Kura Oncology’s reported figures.

total revenue/total assets=0.1×

Based on trailing twelve months.

The source filing: Kura Oncology’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219481

FAQ

What is Kura Oncology's asset turnover?
Kura Oncology (KURA) reported asset turnover of 0.1× in Q1 2026.
How has Kura Oncology's asset turnover changed year-over-year?
Kura Oncology's asset turnover increased by 22.1% year-over-year, from 0.1× to 0.1×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Kura Oncology's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude